Research Output per year
Fingerprint Dive into the research topics where Stephen Moore is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 17 Similar Profiles
Genomic Instability
Medicine & Life Sciences
Radiation
Medicine & Life Sciences
Fluorescence In Situ Hybridization
Medicine & Life Sciences
Mutation Rate
Medicine & Life Sciences
Comparative Genomic Hybridization
Medicine & Life Sciences
Linear Energy Transfer
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1999 2019
A case of recurrent epilepsy-associated rosette-forming glioneuronal tumor with anaplastic transformation in the absence of therapy
Halfpenny, A., Ferris, S. P., Grafe, M., Woltjer, R. R., Selden, N., Nazemi, K., Perry, A., Solomon, D. A., Gultekin, S., Moore, S., Olson, S., Lawce, H., Lucas, L., Corless, C. & Wood, M., Jan 1 2019, (Accepted/In press) In : Neuropathology.Research output: Contribution to journal › Article
Open Access
Epilepsy
Neuroepithelial Neoplasms
Fluorescence In Situ Hybridization
Neoplasms
Temporal Lobe
1
Citation
(Scopus)
Applications of molecular neuro-oncology - A review of diffuse glioma integrated diagnosis and emerging molecular entities
Wood, M., Halfpenny, A. M. & Moore, S., Apr 9 2019, In : Diagnostic Pathology. 14, 1, 29.Research output: Contribution to journal › Review article
Open Access
Glioma
Astrocytoma
Brain Neoplasms
Central Nervous System Neoplasms
Neoplasms
2
Citations
(Scopus)
Two myeloid leukemia cases with rare FLT3 fusions
Zhang, H., Paliga, A., Hobbs, E., Moore, S., Olson, S., Long, N., Dao, K-H. & Tyner, J., Dec 1 2018, In : Cold Spring Harbor molecular case studies. 4, 6Research output: Contribution to journal › Article
Myeloid Leukemia
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
Bone Marrow
Leukemia, Myelomonocytic, Chronic
Myeloproliferative Disorders
2
Citations
(Scopus)
MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes
Raess, P., Moore, S., Cascio, M., Dunlap, J., Fan, G., Gatter, K., Olson, S. & Braziel, R., Sep 5 2017, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.Research output: Contribution to journal › Article
Cytogenetic Analysis
B-Cell Lymphoma
Proto-Oncogene Proteins c-bcl-2
Lymphoma
Cytogenetics
63
Citations
(Scopus)
Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data
Grasso, C., Butler, T., Rhodes, K., Quist, M., Neff, T. L., Moore, S., Tomlins, S. A., Reinig, E., Beadling, C., Andersen, M. & Corless, C., Jan 1 2015, In : Journal of Molecular Diagnostics. 17, 1, p. 53-63 11 p.Research output: Contribution to journal › Article
Libraries
Breast Neoplasms
Matched-Pair Analysis
Precision Medicine
Comparative Genomic Hybridization